We are live on ! Find out more
ATYR

aTyr Pharma
ATYR

17 hedge funds and large institutions have $8.02M invested in aTyr Pharma in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

23% more capital invested

Capital invested by funds: $6.5M → $8.02M (+$1.52M)

1.7% more ownership

Funds ownership: 47.76% → 49.46% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less funds holding

Funds holding: 19 → 17 (-2)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
2
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$174K
2
JMPWA
JP Morgan Private Wealth Advisors
California
+$87.2K
3
Citadel Advisors
Citadel Advisors
Florida
+$53.2K
4
VF
Virtu Financial
New York
+$43.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$24.3K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$107K
2
TRCT
Tower Research Capital (TRC)
New York
-$16.1K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$3.48K
4
Victory Capital Management
Victory Capital Management
Texas
-$2K
5
BlackRock
BlackRock
New York
-$12
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$2.48M +$174K +45,072 +8%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$2.05M – – –
Viking Global Investors
3
Viking Global Investors
Connecticut
$956K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$834K +$24.3K +6,300 +3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$690K -$3.48K -900 -0.5%
PVMCV
6
Polaris Venture Management Co V
Massachusetts
$544K – – –
Ensign Peak Advisors
7
Ensign Peak Advisors
Utah
$158K +$146K +37,884 New
JMPWA
8
JP Morgan Private Wealth Advisors
California
$94K +$87.2K +22,579 New
Citadel Advisors
9
Citadel Advisors
Florida
$57K +$53.2K +13,774 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$54K – – –
VF
11
Virtu Financial
New York
$47K +$43.2K +11,183 New
BlackRock
12
BlackRock
New York
$36K -$12 -3 -0%
UBS Group
13
UBS Group
Switzerland
$14K +$13.3K +3,448 New
TRCT
14
Tower Research Capital (TRC)
New York
$8K -$16.1K -4,181 -70%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
– -$107K -30,576 Closed
Victory Capital Management
16
Victory Capital Management
Texas
– -$2K -443 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– +$4 +1 New

ATYR Hedge Fund Activity: Q4 2019 in Review

17 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q4 2019, worth a combined $8.02M — up 23% from $6.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ATYR positions and 3 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Federated Hermes, adding an estimated $174K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $107K sold.

  • 17 institutional investors held aTyr Pharma (ATYR) as of Q4 2019, down from 19 in Q3 2019.
  • Funds reported $8.02M of aTyr Pharma stock for Q4 2019, up 23% quarter-over-quarter.
  • 6 funds opened new aTyr Pharma positions in Q4 2019 and 3 closed out, a net change of +3 holders.
  • The largest aTyr Pharma buyer in Q4 2019 was Federated Hermes, an estimated $174K added.
  • The largest aTyr Pharma seller in Q4 2019 was Acadian Asset Management, an estimated $107K sold.

Based on aggregated 13F filings for Q4 2019.